WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996006942) GENETICALLY ALTERED T-CELLS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/006942    International Application No.:    PCT/EP1995/003410
Publication Date: 07.03.1996 International Filing Date: 30.08.1995
Chapter 2 Demand Filed:    22.03.1996    
IPC:
A61K 38/00 (2006.01), A61K 38/18 (2006.01), A61K 48/00 (2006.01), C07K 14/48 (2006.01)
Applicants: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. [DE/DE]; D-Berlin (DE) (For All Designated States Except US).
WEKERLE, Hartmut [DE/DE]; (DE) (For US Only).
THOENEN, Hans [CH/DE]; (DE) (For US Only).
KRAMER, Rainer [DE/US]; (US) (For US Only).
ZHANG, Yiping [CN/CA]; (CA) (For US Only)
Inventors: WEKERLE, Hartmut; (DE).
THOENEN, Hans; (DE).
KRAMER, Rainer; (US).
ZHANG, Yiping; (CA)
Agent: VOSSIUS & PARTNER; Postfach 86 07 67, D-81634 München (DE)
Priority Data:
P 44 31 011.0 31.08.1994 DE
60/001,547 27.07.1995 US
Title (DE) GENETISCH VERÄNDERTE T-ZELLEN
(EN) GENETICALLY ALTERED T-CELLS
(FR) LYMPHOCYTES T MODIFIES GENETIQUEMENT
Abstract: front page image
(DE)Die Erfindung betrifft genetisch veränderte reife T-Zellen mit autoreaktiven Rezeptoren, die in ihrem Genom mindestens ein extern eingeführtes Gen tragen, das zur Expression eines (Poly)peptids fähig ist. Die Erfindung betrifft ferner Arzneimittel, die derartige T-Zellen enthalten.
(EN)The invention concerns genetically altered mature T-cells with autoreactive receptors which carry in their genome at least one externally introduced gene which can express a (poly)peptide. The invention further concerns drugs containing such T-cells.
(FR)L'invention concerne des lymphocytes T matures modifiés génétiquement, contenant des récepteurs autoréactifs et comportant dans leur génome au moins un gène, introduit de l'extérieur, pouvant exprimer un (poly)peptide. L'invention concerne en outre des médicaments contenant ces lymphocytes T.
Designated States: AM, AU, BB, BG, BR, BY, CA, CN, CZ, EE, FI, GE, HU, IS, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, RO, RU, SD, SG, SI, SK, TJ, TM, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)